Daysee

Lupin Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 31, 2026
Approval ID: a9861412-4e54-4984-b14c-a1dd91d5c946
Products: 1 registered
Version: 20

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DAYSEE safely and effectively. See full prescribing information for DAYSEE.Daysee [levonorgestrel and ethinyl estradiol tablets USP (0.15 mg/0.03 mg) and ethinyl estradiol tablets USP (0.01 mg)] for oral useInitial U.S. Approval: 1982

Quick Stats

Total Products1

Labelers2

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.